Joseph Schwartz Stock Analyst Profile - Leerink Partners Research Coverage - Stocknear

Joseph Schwartz

Stock Analyst at Leerink Partners

(3.7)
# 2420
Out of 5,504 analysts
185
Total ratings
Success rate
Average return

43 Stocks

Name Action PT Current % Upside Ratings Updated
CRNX Crinetics Pharmaceut...
Maintains: Outperform
80 88
40.62 116.64% 2 Sep 29, 2025
QURE uniQure
Maintains: Outperform
48 68
56.01 21.41% 2 Sep 24, 2025
SRPT Sarepta Therapeutics
Maintains: Market Perform
12 15
22.05 -31.97% 11 Sep 9, 2025
KALV KalVista Pharma
Maintains: Outperform
18 20
11.72 70.65% 6 Jul 7, 2025
INSM Insmed
Maintains: Outperform
100 115
157.64 -27.05% 4 Jun 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
4 12
9.38 27.93% 4 May 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
7
n/a n/a 3 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
28
26.29 6.5% 1 Feb 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
20 40
24.86 60.9% 6 Oct 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
11 14
0.94 1389.36% 2 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 3 Jul 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
12 12
5.88 104.08% 6 Jun 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
6 8
2 300% 2 Jun 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
675 150
8.55 1654.39% 5 Mar 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
1
1.68 -40.48% 4 Feb 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
10
n/a n/a 3 Dec 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
1
n/a n/a 2 Aug 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
6
6.08 -1.32% 4 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
44 40
n/a n/a 3 Jun 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
80 115
n/a n/a 3 Jun 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
48
66.91 -28.26% 1 Mar 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
20 18
23.44 -23.21% 5 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
33 34
69.01 -50.73% 1 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
122 130
55.19 135.55% 10 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
148 163
203.35 -19.84% 15 Jan 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
15 2
n/a n/a 6 Dec 27, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 10
2.6 284.62% 7 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 33
5.29 523.82% 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
17 12
11.29 6.29% 6 Nov 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
115 108
31.02 248.16% 6 Nov 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
64 52
n/a n/a 5 Aug 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
6 4
1.55 158.06% 4 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 30
15.54 93.05% 2 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
53 50
45.45 10.01% 3 May 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
50 30
64.94 -53.8% 6 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
124 4
n/a n/a 6 Apr 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 14
8.39 66.87% 10 Feb 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
112 100
n/a n/a 6 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 2 Dec 12, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
n/a n/a 1 Oct 23, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
10 12
2.38 404.2% 1 Sep 26, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
23
n/a n/a 1 Aug 28, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 3 May 18, 2017